Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Targeting human papillomavirus genome replication for antiviral drug discovery.

Archambault J, Melendy T.

Antivir Ther. 2013;18(3):271-83. doi: 10.3851/IMP2612. Epub 2013 Apr 24. Review.

2.

E1-mediated recruitment of a UAF1-USP deubiquitinase complex facilitates human papillomavirus DNA replication.

Lehoux M, Gagnon D, Archambault J.

J Virol. 2014 Aug;88(15):8545-55. doi: 10.1128/JVI.00379-14. Epub 2014 May 21.

3.

HPV proteins as targets for therapeutic intervention.

Sterlinko Grm H, Banks L.

Antivir Ther. 2004 Oct;9(5):665-78. Review.

PMID:
15535404
4.

A novel drug screening assay for papillomavirus specific antiviral activity.

Clark PR, Roberts ML, Cowsert LM.

Antiviral Res. 1998 Feb;37(2):97-106.

PMID:
9588842
5.

Recent advances in the search for antiviral agents against human papillomaviruses.

Fradet-Turcotte A, Archambault J.

Antivir Ther. 2007;12(4):431-51. Review.

6.

The inhibitory action of P56 on select functions of E1 mediates interferon's effect on human papillomavirus DNA replication.

Saikia P, Fensterl V, Sen GC.

J Virol. 2010 Dec;84(24):13036-9. doi: 10.1128/JVI.01194-10. Epub 2010 Oct 6.

7.

A high capacity assay for inhibitors of human papillomavirus DNA replication.

Plumpton M, Sharp NA, Liddicoat LH, Remm M, Tucker DO, Hughes FJ, Russell SM, Romanos MA.

Biotechnology (N Y). 1995 Nov;13(11):1210-4.

PMID:
9636294
8.

Artificial Recruitment of UAF1-USP Complexes by a PHLPP1-E1 Chimeric Helicase Enhances Human Papillomavirus DNA Replication.

Gagnon D, Lehoux M, Archambault J.

J Virol. 2015 Jun;89(12):6227-39. doi: 10.1128/JVI.00560-15. Epub 2015 Apr 1.

9.

Activity and therapeutic potential of ORI-1001 antisense oligonucleotide on human papillomavirus replication utilizing a model of dysplastic human epithelium.

Alam S, Bromberg-White J, McLaughlin-Drubin M, Sen E, Bodily JM, Meyers C.

Anticancer Res. 2005 Mar-Apr;25(2A):765-77.

10.

Genital human papillomavirus infections: current and prospective therapies.

Stanley MA.

J Gen Virol. 2012 Apr;93(Pt 4):681-91. doi: 10.1099/vir.0.039677-0. Epub 2012 Feb 8. Review.

PMID:
22323530
11.

Inhibition of human papillomavirus DNA replication by small molecule antagonists of the E1-E2 protein interaction.

White PW, Titolo S, Brault K, Thauvette L, Pelletier A, Welchner E, Bourgon L, Doyon L, Ogilvie WW, Yoakim C, Cordingley MG, Archambault J.

J Biol Chem. 2003 Jul 18;278(29):26765-72. Epub 2003 Apr 30.

12.

Molecular targets for papillomavirus therapy.

Wilson VG, Rosas-Acosta G.

Curr Drug Targets Infect Disord. 2003 Sep;3(3):221-39. Review.

PMID:
14529355
13.

The transcription map of HPV11 in U2OS cells adequately reflects the initial and stable replication phases of the viral genome.

Isok-Paas H, Männik A, Ustav E, Ustav M.

Virol J. 2015 Apr 14;12:59. doi: 10.1186/s12985-015-0292-6.

14.

Gene- and protein-delivered zinc finger-staphylococcal nuclease hybrid for inhibition of DNA replication of human papillomavirus.

Mino T, Mori T, Aoyama Y, Sera T.

PLoS One. 2013;8(2):e56633. doi: 10.1371/journal.pone.0056633. Epub 2013 Feb 20.

15.

Efficacy of two commercial preparations of interferon-alpha on human papillomavirus replication.

Sen E, McLaughlin-Drubin M, Meyers C.

Anticancer Res. 2005 Mar-Apr;25(2A):1091-100.

17.
18.
19.

Human papillomavirus E1 and E2 mediated DNA replication is not arrested by DNA damage signalling.

King LE, Fisk JC, Dornan ES, Donaldson MM, Melendy T, Morgan IM.

Virology. 2010 Oct 10;406(1):95-102. doi: 10.1016/j.virol.2010.06.033. Epub 2010 Jul 31.

20.

The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b.

Frattini MG, Laimins LA.

Virology. 1994 Nov 1;204(2):799-804.

PMID:
7941349

Supplemental Content

Support Center